Picture1.jpg
Letter to Oncotelic Shareholders on the Recently Completed Joint Venture Transaction with Dragon Overseas Capital Limited
April 07, 2022 10:00 ET | Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), issued the following shareholder letter today. Dear Fellow...
Intermountain Healthcare Logo
Intermountain Healthcare Researchers Play Key Role in New Study Finding Antiviral Drug is Effective in Preventing Severe Illness in COVID Patients When Given Early
December 22, 2021 17:48 ET | Intermountain Healthcare
Salt Lake City, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Researchers from Intermountain Healthcare played a key role in a new international study that has found that an antiviral drug designed to inhibit...
Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line
July 20, 2020 07:30 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving new data from ongoing...
Colorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry
July 08, 2020 13:47 ET | New Iridium
BOULDER, Colo., July 08, 2020 (GLOBE NEWSWIRE) -- New Iridium, a company developing commercialized  photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a...
Politicized COVID-19 Response Imperils Both Freedom and Safety, States Journal of American Physicians and Surgeons
June 22, 2020 10:46 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., June 22, 2020 (GLOBE NEWSWIRE) -- Based on seriously flawed statistical models, government has seized unprecedented powers, claiming to protect us from the COVID-19 pandemic, writes...